.png)
Summary & Headlines:
Disease Management / Digital Therapeutics
In late 2025 and early 2026, disease management and digital therapeutics activity focused on integrating technology-enabled care into existing clinical workflows, with collaborations like Thyme Care’s oncology support embedded in primary care and CMS’s ACCESS model aligning reimbursement to incentivize telehealth, remote monitoring, and digital tools for chronic condition management.
Informatics / Healthcare IT Solutions
In early 2026, informatics and healthcare IT innovation emphasized responsible AI embedded into core clinical and administrative workflows, with initiatives like Utah’s autonomous AI prescription-renewal pilot and Included Health’s clinician-supervised AI assistant using integrated health data to reduce burden, improve efficiency, and enhance patient navigation while maintaining oversight and safety.
Women’s Health / Femtech
In late 2025 and early 2026, women’s health and femtech innovation spanned care delivery, diagnostics, and foundational research, with companies like Origin scaling hybrid digital-plus-in-person models, Inito advancing AI-enabled at-home biomarker testing, and public funding in Ireland laying the groundwork for evidence-based digital tools and platforms that address long-standing gaps in women’s healthcare.
Wellness / Longevity
In late 2025 and early 2026, healthy aging and longevity innovation increasingly centered on data-driven prevention, with companies like Withings and Noom combining connected devices, at-home biomarker testing, AI-driven insights, and digital behavior-change platforms to help individuals monitor physiological aging, intervene earlier, and extend healthspan rather than react to disease.
Table of Contents:
Disease Management / Digital Therapeutics
1 | Thyme Care collaborates with senior primary care centers to support cancer management
Informatics / Healthcare IT Solutions
1 | Utah and Doctronic partner to enable AI to renew prescriptions autonomously
2 | Included Health launches AI personal health assistant
Women’s Health / Femtech
1 | Origin raises Series B to scale hybrid model for women’s musculoskeletal care
Healthy Aging / Longevity
1 | Withings aims to redefine preventive health with Body Scan 2 longevity station
2 | Noom launches longevity-focused digital health program combining GLP-1 medication with at-home biomarker testing
Disease Management / Digital Therapeutics
1 | Thyme Care collaborates with senior primary care centers to support cancer management
January 2026: Thyme Care has partnered with CenterWell Senior Primary Care and Conviva Senior Primary Care to integrate cancer care support into senior-focused primary care practices across several U.S. states. Through the collaboration, eligible patients will gain access to Thyme Care’s oncology-trained clinicians, virtual care navigation, and symptom tracking tools, supplementing the support provided by their primary care physicians. The goal is to help patients manage cancer diagnoses, remain connected to their care teams, and navigate treatment more effectively, while allowing primary care providers to draw on specialized oncology resources without shifting care away from the primary care setting.
December 2025: The ACCESS (Advancing Chronic Care with Effective, Scalable Solutions) Model is a voluntary, nationwide alternative payment model introduced by CMS that shifts Medicare payments away from fee-for-service toward outcome-aligned payments for managing chronic conditions such as hypertension, diabetes, chronic pain, and depression. By tying payments to measurable improvements in patient health rather than individual services, the model encourages clinicians and care teams to integrate technology-enabled tools like telehealth, remote monitoring devices, and digital coaching platforms into chronic disease management. This approach can reduce barriers to digital health adoption, enabling providers to use wearables, connected devices, and digital therapeutics more systematically to support continuous care outside traditional office visits. Ultimately, ACCESS aims to modernize care delivery by supporting digital health innovations that help improve outcomes for patients with long-term conditions while also aligning financial incentives with value-based care.
Informatics / Healthcare IT Solutions
1 | Utah and Doctronic partner to enable AI to renew prescriptions autonomously
January 2026: Utah has launched a pilot program that allows an autonomous AI system developed by Doctronic to participate in routine prescription renewals for patients with chronic conditions, making it the first state-approved initiative of its kind. Operating within the state’s regulatory sandbox, the program will evaluate whether AI-assisted refills can reduce delays, improve medication adherence, and ease administrative burden while maintaining clinical oversight and patient safety. State officials will assess real-world outcomes such as refill timeliness, safety, patient experience, workflow impact, and costs, and share results publicly to inform future policy.
2 | Included Health launches AI personal health assistant
Included Health, a digital health and care navigation provider, has launched Dot, an AI-powered personal health assistant designed to help patients interact with their healthcare using integrated claims, benefits, and medical data. Dot leverages informatics combining longitudinal clinical and benefits data to deliver personalized guidance on topics like coverage, visit preparation, and care navigation. The assistant is built with a clinician-in-the-loop model, meaning human care advocates and clinicians can intervene when more complex or urgent issues arise, merging AI automation with traditional care support. With Dot serving as a front door to Included Health’s broader platform, the company is positioning itself in the healthcare IT space as a competitor to Big Tech’s AI health efforts by blending advanced analytics, enterprise data integration, and human oversight to improve patient experience and care coordination.
Women’s Health / Femtech
1 | Origin raises Series B to scale hybrid model for women’s musculoskeletal care
January 2026: Origin, a U.S. women’s health provider focused on pelvic floor physical therapy and broader musculoskeletal conditions, announced a new Series B funding round to scale its hybrid care model. The company combines virtual care delivery with in-person clinics, enabling women across the U.S. to access licensed physical therapists digitally or on site. Origin has treated tens of thousands of patients through this hybrid model and developed tools such as a patient app and AI-assisted clinician support, illustrating its integration of technology with clinical care. The Series B capital is intended to expand both the virtual and physical footprint and invest in technology and research to further enhance access, affordability, and outcomes in women’s musculoskeletal health.
December 2025: The Irish Department of Health announced €2 million in dedicated funding for women’s health research over 2026–2027, marking the first time the country has ring-fenced public research dollars specifically for this area. Although not tied to a single company, this investment is material for the femtech and digital health ecosystem because it creates structured funding opportunities (via Applied Partnership Awards) for projects focused on conditions disproportionately affecting women, such as endometriosis, menstruation, and postpartum mental health. By supporting research that aims to generate evidence and understanding of women’s health gaps, the program aims to catalyze new evidence-based digital tools and data platforms that directly address unmet needs in women’s care. The formal call for proposals also positions academic, clinical, and femtech innovators to compete for funding that will inform new product development and digital health solutions tailored to women’s health.
December 2025: Inito announced a $29 million Series B funding round to accelerate the next generation of at-home health diagnostics, expanding beyond its original fertility tracking tools. The company’s platform uses AI-engineered antibodies and machine learning to interpret hormone and health biomarkers, enabling users to perform accurate, clinical-grade tests from home rather than in a lab. These tools aim to allow patients to monitor reproductive and hormonal health autonomously while receiving actionable insights via connected software. The new funding will support broader test development for additional biomarkers, global expansion, and enhanced diagnostic capabilities across women’s and general health needs.
Healthy Aging / Longevity
1 | Withings aims to redefine preventive health with Body Scan 2 longevity station
January 2026: Withings unveiled the Body Scan 2, positioning it as the world’s first science-backed longevity station designed to bring deep preventive health insights into the home, using advanced connected device technology to extend healthspan and detect early physiological changes. The device captures over 60 clinically selected biomarkers in about 90 seconds, including cardiac pumping efficiency, arterial health, cellular health and metabolic efficiency, and early glycemic regulation signals, all intended to flag risks years before visible symptoms emerge. Withings integrates these biomarker readings into an AI-driven health trajectory score and personalized recommendations, turning everyday use into continuous monitoring that supports longitudinal trend tracking and informed lifestyle changes.
December 2025: Noom launched a preventive health program that integrates microdosed GLP-1 medication with digital health tools, including at-home biomarker testing every four months and a behavior-change mobile application. The program provides members with 17 advanced lab markers tracked through home testing, with results and personalized insights delivered directly through Noom's digital platform. By combining medication with app-based habit tracking and biomarker monitoring, the program aims to help adults proactively address metabolic health markers before chronic disease develops.
.png)
